ArticleJournal of gastric cancer2026

The CALLY Index for Unresectable or Recurrent Gastric Cancer Treated With Nivolumab: A Multicenter Retrospective Study.

Kenji Takeshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.